-
Innovation Ranking
NewInnovation Ranking – KB Financial Group Inc
KB Financial Group Inc (KBFGI), through its subsidiaries, offers a diversified range of banking, insurance solutions, and other related financial products and services. Its product portfolio includes personal and corporate loans, demand and term deposits, debit and credit cards, and insurance coverage for life and non-life. KBFGI’s service offerings include trading, asset management, brokerage, treasury, trust services, information technology outsourcing, capital markets, and international banking services. The group offers products and services to individuals, small and medium-sized entrepreneurs, and large...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-707 in Osteosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-707 in Osteosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-707 in Osteosarcoma Drug Details: KB-707 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-707 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-707 in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-707 in Metastatic Melanoma Drug Details: KB-707 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-707 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-707 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-707 in Solid Tumor Drug Details: KB-707 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-707 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-707 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-707 in Non-Small Cell Lung Cancer Drug Details: KB-707...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD) Drug Details: KB-408 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Rhabdomyosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Rhabdomyosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Rhabdomyosarcoma Drug Details: KB-0742 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Colorectal Cancer Drug Details: KB-0742 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Bladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Bladder Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Bladder Cancer Drug Details: KB-0742 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-0742 in Rectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-0742 in Rectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-0742 in Rectal Cancer Drug Details: KB-0742 is under development for...